$KBDC
Kayne Anderson BDC Inc Stock $kbdc

$kbdc Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000121390024097564 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$37.05M
YoY Change		73.4%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses		$27.56M
YoY Change		39.01%
Operating Profit		-$20.77M
YoY Change		-1034.56%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings		$37.56M
YoY Change		170.73%
Net Earnings / Revenue		101.36%
Basic Earnings Per Share		$0.52
Diluted Earnings Per Share		$0.52
COMMON SHARES
Basic Shares Outstanding	71.03M shares	71.09M shares
Diluted Shares Outstanding		71.08M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents		$39.08M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments		$20.23M
YoY Change		-98.44%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets		$2.028B
YoY Change		53.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities		$842.0M
YoY Change		31.59%
SHAREHOLDERS EQUITY
Retained Earnings		$33.13M
YoY Change		172.05%
Common Stock		$1.153B
YoY Change		72.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$1.186B
YoY Change
Total Liabilities & Shareholders Equity		$2.028B
YoY Change		53.58%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		$37.56M
YoY Change		170.73%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2024Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2023Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-0531326
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77002
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	KBDC
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	814-01363
	dei	Entity Registrant Name EntityRegistrantName	Kayne Anderson BDC, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	717 Texas Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 2200
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	City Area Code CityAreaCode	(713)
	dei	Local Phone Number LocalPhoneNumber	493-2020
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71026111	shares
CY2024Q3	kbdc	Shortterm Investmentsamortized Cost ShorttermInvestmentsamortizedCost	22670000	usd
CY2023Q4	kbdc	Shortterm Investmentsamortized Cost ShorttermInvestmentsamortizedCost	12802000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	22670000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	12802000	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39083000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34069000	usd
CY2024Q3	kbdc	Receivable For Principal Payments On Investments ReceivableForPrincipalPaymentsOnInvestments	501000	usd
CY2023Q4	kbdc	Receivable For Principal Payments On Investments ReceivableForPrincipalPaymentsOnInvestments	104000	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	22391000	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	12874000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	161000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	319000	usd
CY2024Q3	us-gaap	Assets Assets	2028245000	usd
CY2023Q4	us-gaap	Assets Assets	1423666000	usd
CY2024Q3	us-gaap	Line Of Credit LineOfCredit	221000000	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	234000000	usd
CY2024Q3	kbdc	Unamortized Corporate Credit Facility Issuance Costs UnamortizedCorporateCreditFacilityIssuanceCosts	-1127000	usd
CY2023Q4	kbdc	Unamortized Corporate Credit Facility Issuance Costs UnamortizedCorporateCreditFacilityIssuanceCosts	-1715000	usd
CY2024Q3	kbdc	Revolving Funding Facility Note RevolvingFundingFacilityNote	409000000	usd
CY2023Q4	kbdc	Revolving Funding Facility Note RevolvingFundingFacilityNote	306000000	usd
CY2024Q3	kbdc	Unamortized Revolving Funding Facility Issuance Costs UnamortizedRevolvingFundingFacilityIssuanceCosts	-5277000	usd
CY2023Q4	kbdc	Unamortized Revolving Funding Facility Issuance Costs UnamortizedRevolvingFundingFacilityIssuanceCosts	-2019000	usd
CY2024Q3	kbdc	Revolving Funding Facility Ii Note RevolvingFundingFacilityIINote	83000000	usd
CY2023Q4	kbdc	Revolving Funding Facility Ii Note RevolvingFundingFacilityIINote	70000000	usd
CY2024Q3	kbdc	Unamortized Revolving Funding Facility Ii Issuance Costs UnamortizedRevolvingFundingFacilityIIIssuanceCosts	-1411000	usd
CY2023Q4	kbdc	Unamortized Revolving Funding Facility Ii Issuance Costs UnamortizedRevolvingFundingFacilityIIIssuanceCosts	-1805000	usd
CY2023Q4	kbdc	Subscription Credit Agreement SubscriptionCreditAgreement	10750000	usd
CY2023Q4	kbdc	Unamortized Subscription Credit Facility Issuance Costs UnamortizedSubscriptionCreditFacilityIssuanceCosts	-41000	usd
CY2024Q3	kbdc	Senior Unsecured Notes SeniorUnsecuredNotes	75000000	usd
CY2023Q4	kbdc	Senior Unsecured Notes SeniorUnsecuredNotes	75000000	usd
CY2024Q3	kbdc	Unamortized Notes Issuance Costs UnamortizedNotesIssuanceCosts	-696000	usd
CY2023Q4	kbdc	Unamortized Notes Issuance Costs UnamortizedNotesIssuanceCosts	-851000	usd
CY2024Q3	us-gaap	Payable Investment Purchase PayableInvestmentPurchase	17397000	usd
CY2024Q3	us-gaap	Other Notes Payable OtherNotesPayable	10000	usd
CY2024Q3	us-gaap	Distribution Payable DistributionPayable	28420000	usd
CY2023Q4	us-gaap	Distribution Payable DistributionPayable	22050000	usd
CY2024Q3	us-gaap	Management Fee Payable ManagementFeePayable	3573000	usd
CY2023Q4	us-gaap	Management Fee Payable ManagementFeePayable	2996000	usd
CY2023Q4	us-gaap	Incentive Fee Payable IncentiveFeePayable	14195000	usd
CY2024Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	13151000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	11949000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	101000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	842040000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	740610000	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71047779	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71047779	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41603666	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41603666	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	42000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1153001000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	669990000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	33133000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13024000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1186205000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	683056000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2028245000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1423666000	usd
CY2024Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.7
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.42
CY2024Q3	us-gaap	Investment Income Dividend InvestmentIncomeDividend	278000	usd
CY2023Q3	us-gaap	Investment Income Dividend InvestmentIncomeDividend	156000	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	997000	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	349000	usd
CY2024Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	57819000	usd
CY2023Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	41197000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	156766000	usd
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	118309000	usd
CY2024Q3	us-gaap	Management Fee Expense ManagementFeeExpense	4764000	usd
CY2023Q3	us-gaap	Management Fee Expense ManagementFeeExpense	2905000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	12537000	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	8438000	usd
CY2024Q3	us-gaap	Incentive Fee Expense IncentiveFeeExpense	5605000	usd
CY2023Q3	us-gaap	Incentive Fee Expense IncentiveFeeExpense	2371000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	12345000	usd
	us-gaap	Incentive Fee Expense IncentiveFeeExpense	6929000	usd
CY2024Q3	us-gaap	Interest Expense Operating InterestExpenseOperating	16069000	usd
CY2023Q3	us-gaap	Interest Expense Operating InterestExpenseOperating	13871000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	44964000	usd
	us-gaap	Interest Expense Operating InterestExpenseOperating	38396000	usd
CY2024Q3	us-gaap	Professional Fees ProfessionalFees	403000	usd
CY2023Q3	us-gaap	Professional Fees ProfessionalFees	189000	usd
	us-gaap	Professional Fees ProfessionalFees	1042000	usd
	us-gaap	Professional Fees ProfessionalFees	482000	usd
CY2024Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	158000	usd
CY2023Q3	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	147000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	463000	usd
	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	464000	usd
CY2024Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	563000	usd
CY2023Q3	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	345000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1542000	usd
	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	1216000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	27562000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	19828000	usd
	us-gaap	Operating Expenses OperatingExpenses	72893000	usd
	us-gaap	Operating Expenses OperatingExpenses	55925000	usd
CY2024Q3	kbdc	Investment Company Management Fee Waiver InvestmentCompanyManagementFeeWaiver	1191000	usd
	kbdc	Investment Company Management Fee Waiver InvestmentCompanyManagementFeeWaiver	1662000	usd
CY2024Q3	kbdc	Investment Company Incentive Fee Waiver InvestmentCompanyIncentiveFeeWaiver	5605000	usd
	kbdc	Investment Company Incentive Fee Waiver InvestmentCompanyIncentiveFeeWaiver	9714000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-20766000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-19828000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-61517000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-55925000	usd
CY2024Q3	us-gaap	Net Investment Income NetInvestmentIncome	37053000	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	21369000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	95249000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	62384000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-138000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	503000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7497000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1380000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8103000	usd
CY2024Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	503000	usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	-7497000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	1242000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-8103000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	37556000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	13872000	usd
	us-gaap	Net Income Loss NetIncomeLoss	96491000	usd
	us-gaap	Net Income Loss NetIncomeLoss	54281000	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.53
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.55
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.62
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.53
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.53
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.34
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.57
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.57
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.41
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.41
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71083885	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71083885	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40499327	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40499327	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61321163	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61321163	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38461385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38461385	shares
CY2024Q3	us-gaap	Net Investment Income NetInvestmentIncome	37053000	usd
CY2023Q3	us-gaap	Net Investment Income NetInvestmentIncome	21369000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	95249000	usd
	us-gaap	Net Investment Income NetInvestmentIncome	62384000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-138000	usd
CY2024Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	503000	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-7497000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1380000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8103000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	37556000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	13872000	usd
	us-gaap	Net Income Loss NetIncomeLoss	96491000	usd
	us-gaap	Net Income Loss NetIncomeLoss	54281000	usd
CY2024Q3	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	28420000	usd
CY2023Q3	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	21999000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	76382000	usd
	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	59567000	usd
CY2024Q3	kbdc	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-28420000	usd
CY2023Q3	kbdc	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-21999000	usd
	kbdc	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-76382000	usd
	kbdc	Net Decrease In Net Assets Resulting From Stockholder Distributions NetDecreaseInNetAssetsResultingFromStockholderDistributions	-59567000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	40575000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	480997000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	90575000	usd
CY2024Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1107000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1107000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	1352000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	3150000	usd
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	3396000	usd
CY2024Q3	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	-1107000	usd
CY2023Q3	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	41927000	usd
	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	483040000	usd
	us-gaap	Investment Company Increase Decrease From Share Transaction InvestmentCompanyIncreaseDecreaseFromShareTransaction	93971000	usd
CY2024Q3	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	8029000	usd
CY2023Q3	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	33800000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	503149000	usd
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	88685000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1178176000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	646926000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	683056000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	592041000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1186205000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	680726000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	1186205000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	680726000	usd
	us-gaap	Net Income Loss NetIncomeLoss	96491000	usd
	us-gaap	Net Income Loss NetIncomeLoss	54281000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-138000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1380000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-8103000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	8571000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	6760000	usd
	kbdc	Salespurchases Of Shortterm Investments Net SalespurchasesOfShorttermInvestmentsNet	-9868000	usd
	kbdc	Salespurchases Of Shortterm Investments Net SalespurchasesOfShorttermInvestmentsNet	-6781000	usd
	kbdc	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	784316000	usd
	kbdc	Purchases Of Portfolio Investments PurchasesOfPortfolioInvestments	217836000	usd
	kbdc	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	216307000	usd
	kbdc	Proceeds From Sales Of Investments And Principal Repayments ProceedsFromSalesOfInvestmentsAndPrincipalRepayments	105319000	usd
	kbdc	Paidinkind Interest From Portfolio Investments PaidinkindInterestFromPortfolioInvestments	2119000	usd
	kbdc	Paidinkind Interest From Portfolio Investments PaidinkindInterestFromPortfolioInvestments	1310000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2771000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1936000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	9517000	usd
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	3274000	usd
	kbdc	Increasedecrease In Receivable For Principal Payments On Investments IncreasedecreaseInReceivableForPrincipalPaymentsOnInvestments	397000	usd
	kbdc	Increasedecrease In Receivable For Principal Payments On Investments IncreasedecreaseInReceivableForPrincipalPaymentsOnInvestments	68000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-101000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-158000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-228000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	17397000	usd
	us-gaap	Increase Decrease In Payable For Investment Purchased IncreaseDecreaseInPayableForInvestmentPurchased	-956000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	577000	usd
	us-gaap	Increase Decrease In Management Fee Payable IncreaseDecreaseInManagementFeePayable	490000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	-14195000	usd
	us-gaap	Increase Decrease In Incentive Fee Payable IncreaseDecreaseInIncentiveFeePayable	6930000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1202000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	3397000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-495423000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-56301000	usd
	kbdc	Borrowingspayments On Corporate Credit Facility Net BorrowingspaymentsOnCorporateCreditFacilityNet	13000000	usd
	kbdc	Borrowingspayments On Corporate Credit Facility Net BorrowingspaymentsOnCorporateCreditFacilityNet	77000000	usd
	kbdc	Borrowings On Revolving Funding Facility Net BorrowingsOnRevolvingFundingFacilityNet	103000000	usd
	kbdc	Borrowings On Revolving Funding Facility Net BorrowingsOnRevolvingFundingFacilityNet	106000000	usd
	kbdc	Borrowings On Revolving Funding Facility Ii Net BorrowingsOnRevolvingFundingFacilityIINet	13000000	usd
	kbdc	Borrowings On Subscription And Credit Agreement Net BorrowingsOnSubscriptionAndCreditAgreementNet	-10750000	usd
	kbdc	Borrowings On Subscription And Credit Agreement Net BorrowingsOnSubscriptionAndCreditAgreementNet	-83000000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4851000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1816000	usd
	kbdc	Deposits For Issuance Of Common Shares DepositsForIssuanceOfCommonShares	-10000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	66862000	usd
	us-gaap	Payments Of Capital Distribution PaymentsOfCapitalDistribution	49600000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	480997000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	90575000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	75000000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1107000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	500437000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	60159000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5014000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3858000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34069000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8526000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	39083000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12384000	usd
	us-gaap	Interest Paid Net InterestPaidNet	40891000	usd
	us-gaap	Interest Paid Net InterestPaidNet	32882000	usd
	kbdc	Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends NoncashFinancingActivitiesNotIncludedHereinConsistedOfReinvestmentOfDividends	3150000	usd
	kbdc	Noncash Financing Activities Not Included Herein Consisted Of Reinvestment Of Dividends NoncashFinancingActivitiesNotIncludedHereinConsistedOfReinvestmentOfDividends	3396000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">C.<i> Use of Estimates </i>— the preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of income and expenses during the period. Actual results could differ materially from those estimates.</p>
	kbdc	Third Party Valuation Percentage ThirdPartyValuationPercentage	0.25	pure
	us-gaap	Paid In Kind Interest PaidInKindInterest	2119000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1310000	usd
	kbdc	Aggregate Interest Income AggregateInterestIncome	0.014	pure
	kbdc	Aggregate Interest Income AggregateInterestIncome	0.011	pure
	kbdc	Distributions Percentage DistributionsPercentage	0.90	pure
	us-gaap	Quarterly Financial Information Income Taxes Significant Variation Description QuarterlyFinancialInformationIncomeTaxesSignificantVariationDescription	All RICs are subject to a non-deductible 4% excise tax on income that is not distributed on a timely basis in accordance with the calendar year distribution requirements. To avoid the tax, the Company must distribute during each calendar year an amount at least equal to the sum of (i) 98% of its ordinary income for the calendar year, (ii) 98.2% of its net capital gains for the one-year period ending on December 31, the last day of our taxable year, and (iii) undistributed amounts from previous years on which the Company paid no U.S. federal income tax.
	us-gaap	Management And Service Fees Base Rate ManagementAndServiceFeesBaseRate	0.01	pure
CY2024Q3	us-gaap	Payment For Management Fee PaymentForManagementFee	3573000	usd
CY2024Q3	kbdc	Management Fees Expense Net Of Waivers ManagementFeesExpenseNetOfWaivers	1191000	usd
CY2023Q3	us-gaap	Payment For Management Fee PaymentForManagementFee	2905000	usd
	us-gaap	Payment For Management Fee PaymentForManagementFee	10875000	usd
	kbdc	Management Fees Expense Net Of Waivers ManagementFeesExpenseNetOfWaivers	1662000	usd
	us-gaap	Payment For Management Fee PaymentForManagementFee	8438000	usd
	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.015	pure
	us-gaap	Investment Company Total Return After Incentive Fees InvestmentCompanyTotalReturnAfterIncentiveFees	0.06	pure
	us-gaap	Incentive Fee Description IncentiveFeeDescription	Prior to the IPO Date, the income incentive fee is calculated as 100% of our pre-incentive fee net investment income for the immediately preceding calendar quarter in excess of 1.50% of the Company’s NAV at the end of the immediately preceding calendar quarter until the Advisor has received 10% of the total pre-incentive fee net income for that calendar quarter and, for pre-incentive fee net investment income in excess of 1.6667%, 10% of all remaining pre-incentive fee net investment income for that quarter.
	kbdc	Percentage Of First Quarter Hurdle Rate PercentageOfFirstQuarterHurdleRate	0.015	pure
	kbdc	Percentage Of Annual Hurdle Rate PercentageOfAnnualHurdleRate	0.06	pure
	kbdc	Percentage Of Aggregate Pre Incentive Fee Exceeds Hurdle Rate For Quarter PercentageOfAggregatePreIncentiveFeeExceedsHurdleRateForQuarter	1	pure
	kbdc	Percentage Of Minimum Quarterly Rate Before Initial Public Offering PercentageOfMinimumQuarterlyRateBeforeInitialPublicOffering	0.016667	pure
	kbdc	Percentage Of Minimum Quarterly Rate After Initial Public Offering PercentageOfMinimumQuarterlyRateAfterInitialPublicOffering	0.017647	pure
	kbdc	Percentage Of Pre Incentive Fee Before The Initial Public Offering PercentageOfPreIncentiveFeeBeforeTheInitialPublicOffering	0.10	pure
	kbdc	Percentage Of Pre Incentive Fee After The Initial Public Offering PercentageOfPreIncentiveFeeAfterTheInitialPublicOffering	0.15	pure
	kbdc	Percentage Of Aggregate Pre Incentive Fee Exceeds Quarterly Rate PercentageOfAggregatePreIncentiveFeeExceedsQuarterlyRate	0.10	pure
	kbdc	Percentage Of Maximum Quarterly Rate Before The Ipo PercentageOfMaximumQuarterlyRateBeforeTheIPO	0.016667	pure
	kbdc	Percentage Of Pre Incentive Fee Net Investment Income Exceeds Quarterly Rate For First Quarter PercentageOfPreIncentiveFeeNetInvestmentIncomeExceedsQuarterlyRateForFirstQuarter	0.15	pure
	kbdc	Percentage Of Quarterly Rate Exceeds For First Quarter PercentageOfQuarterlyRateExceedsForFirstQuarter	0.017647	pure
	kbdc	Percentage Of Trailing Twelve Quarter Equals Hurdle Rate For Quarter PercentageOfTrailingTwelveQuarterEqualsHurdleRateForQuarter	0.015	pure
	kbdc	Percentage Of Trailing Twelve Quarter Equals Hurdle Rate For Annual PercentageOfTrailingTwelveQuarterEqualsHurdleRateForAnnual	0.06	pure
	kbdc	Percentage Of Aggregate Pre Incentive Fee Exceeds Hurdle Rate For Trailing Twelve Quarters PercentageOfAggregatePreIncentiveFeeExceedsHurdleRateForTrailingTwelveQuarters	1	pure
	kbdc	Percentage Of Computation For Catch Up Amount PercentageOfComputationForCatchUpAmount	0.017647	pure
	kbdc	Percentage Of Aggregate Pre Incentive Fee Exceeds Catch Up Amount For Trailing Twelve Quarter PercentageOfAggregatePreIncentiveFeeExceedsCatchUpAmountForTrailingTwelveQuarter	0.15	pure
	kbdc	Percentage Of Cumulative Pre Incentive Fee Net Return Under Trailing Twelve Quarter PercentageOfCumulativePreIncentiveFeeNetReturnUnderTrailingTwelveQuarter	0.15	pure
	kbdc	Percentage Of Realized Capital Gains Payable Prior The Effective Date PercentageOfRealizedCapitalGainsPayablePriorTheEffectiveDate	0.10	pure
	kbdc	Percentage Of Realized Capital Gains Payable Upon The Effective Date PercentageOfRealizedCapitalGainsPayableUponTheEffectiveDate	0.15	pure
	kbdc	Percentage Of Computation For Capital Gain Incentive Fee PercentageOfComputationForCapitalGainIncentiveFee	0.10	pure
CY2024Q1	us-gaap	Accretion Expense AccretionExpense	16826000	usd
CY2024Q3	us-gaap	Other Assets OtherAssets	184696000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	68578000	usd
CY2024Q3	kbdc	Longterm Investments Fair Value Percentage LongtermInvestmentsFairValuePercentage	1	pure
CY2023Q4	kbdc	Longterm Investments Fair Value Percentage LongtermInvestmentsFairValuePercentage	1	pure
CY2024Q3	us-gaap	Investments Investments	1923211000	usd
CY2024Q3	us-gaap	Equity Method Investments EquityMethodInvestments	20228000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	22670000	usd
CY2024Q3	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1966109000	usd
CY2023Q4	us-gaap	Investments Investments	1346174000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	17324000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	12802000	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	1376300000	usd
CY2024Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1574397000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	177578000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-82805000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	1223000	usd
CY2024Q3	kbdc	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	3326000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1673719000	usd
CY2023Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1283951000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	40482000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-41776000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-7497000	usd
CY2023Q3	kbdc	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	2443000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1277603000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1363498000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	453780000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-155667000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	3315000	usd
	kbdc	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	8793000	usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1673719000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1165119000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	219146000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	-105319000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-8103000	usd
	kbdc	Fair Value Measurement With Unobservable Input Reconciliation Recurring Basis Net Accretion Of Discount On Investments FairValueMeasurementWithUnobservableInputReconciliationRecurringBasisNetAccretionOfDiscountOnInvestments	6760000	usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1277603000	usd
	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0125	pure
CY2024Q3	us-gaap	Other Borrowings OtherBorrowings	83000000	usd
	kbdc	Extension Fee ExtensionFee	0.00075	pure
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	75000000	usd
CY2024Q3	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	696000	usd
CY2024Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	82566000	usd
CY2024Q3	us-gaap	Investment Company Senior Security Indebtedness Asset Coverage Ratio InvestmentCompanySeniorSecurityIndebtednessAssetCoverageRatio	1.50	pure
	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1225000000	usd
CY2024Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	788000000	usd
CY2024Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	437000000	usd
CY2024Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	779489000	usd
CY2023	us-gaap	Line Of Credit Facility Commitment Fee Amount LineOfCreditFacilityCommitmentFeeAmount	1130000000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	695750000	usd
CY2023Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	233502000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	689319000	usd
CY2024Q3	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	6431000	usd
CY2024Q3	us-gaap	Interest Expense Other InterestExpenseOther	15122000	usd
CY2023Q3	us-gaap	Interest Expense Other InterestExpenseOther	13119000	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	947000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	752000	usd
CY2024Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	16069000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	13871000	usd
CY2024Q3	kbdc	Interest Expense Borrowing InterestExpenseBorrowing	731272000	usd
CY2023Q3	kbdc	Interest Expense Borrowing InterestExpenseBorrowing	617598000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	42193000	usd
	us-gaap	Interest Expense Other InterestExpenseOther	36460000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2771000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1936000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	44964000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	38396000	usd
	kbdc	Interest Expense Borrowing InterestExpenseBorrowing	668219000	usd
	kbdc	Interest Expense Borrowing InterestExpenseBorrowing	625421000	usd
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.2
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.53
CY2024Q3	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	4431000	usd
CY2024Q4	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	4521000	usd
CY2024Q3	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	179008000	usd
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	147928000	usd
CY2024Q3	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	179008000	usd
CY2023Q4	us-gaap	Fair Value Investments Entities That Calculate Net Asset Value Per Share Unfunded Committments FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments	147928000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	37556000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	13872000	usd
	us-gaap	Net Income Loss NetIncomeLoss	96491000	usd
	us-gaap	Net Income Loss NetIncomeLoss	54281000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	71083885	shares
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	71083885	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40499327	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40499327	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	61321163	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61321163	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38461385	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38461385	shares
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.53
CY2024Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.53
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.34
CY2023Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.34
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.57
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.57
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.41
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.41
CY2023Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.42
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.5
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.55
	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	1.62
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.04
	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	-0.19
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.59
	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.43
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.2
	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.53
	kbdc	Net Decrease In Net Assets Resulting From Distributions Subtotal NetDecreaseInNetAssetsResultingFromDistributionsSubtotal	-1.2
	kbdc	Net Decrease In Net Assets Resulting From Distributions Subtotal NetDecreaseInNetAssetsResultingFromDistributionsSubtotal	-1.53
	us-gaap	Investment Company Issuance Of Shares Per Share InvestmentCompanyIssuanceOfSharesPerShare	0.11
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.11
CY2024Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.7
CY2023Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	16.4
CY2024Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	16.21
CY2024Q3	us-gaap	Shares Outstanding SharesOutstanding	71047779	shares
CY2023Q3	us-gaap	Shares Outstanding SharesOutstanding	41506935	shares
CY2024Q3	us-gaap	Net Regulatory Assets NetRegulatoryAssets	1186205000	usd
CY2023Q3	us-gaap	Net Regulatory Assets NetRegulatoryAssets	680726000	usd
	kbdc	Weightedaverage Shares Outstandingin Shares WeightedaverageSharesOutstandinginShares	61321163	shares
	kbdc	Weightedaverage Shares Outstandingin Shares WeightedaverageSharesOutstandinginShares	38461385	shares
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.094	pure
	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.089	pure
	us-gaap	Investment Company Total Return Market Value InvestmentCompanyTotalReturnMarketValue	0.024	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.125	pure
	us-gaap	Investment Company Portfolio Turnover InvestmentCompanyPortfolioTurnover	0.085	pure
	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.101	pure
	us-gaap	Investment Company Expense Ratio Excluding Incentive Fee InvestmentCompanyExpenseRatioExcludingIncentiveFee	0.119	pure
	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.085	pure
	us-gaap	Investment Company Expense Ratio Including Incentive Fee InvestmentCompanyExpenseRatioIncludingIncentiveFee	0.119	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.132	pure
	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.133	pure
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	kbdc	Subscription Credit Agreement SubscriptionCreditAgreement		usd
CY2024Q3	kbdc	Unamortized Subscription Credit Facility Issuance Costs UnamortizedSubscriptionCreditFacilityIssuanceCosts		usd
CY2023Q4	us-gaap	Payable Investment Purchase PayableInvestmentPurchase		usd
CY2023Q4	us-gaap	Other Notes Payable OtherNotesPayable		usd
CY2024Q3	us-gaap	Incentive Fee Payable IncentiveFeePayable		usd
CY2023Q3	kbdc	Investment Company Management Fee Waiver InvestmentCompanyManagementFeeWaiver		usd
	kbdc	Investment Company Management Fee Waiver InvestmentCompanyManagementFeeWaiver		usd
CY2023Q3	kbdc	Investment Company Incentive Fee Waiver InvestmentCompanyIncentiveFeeWaiver		usd
	kbdc	Investment Company Incentive Fee Waiver InvestmentCompanyIncentiveFeeWaiver		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2024Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
CY2024Q3	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan		usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
	kbdc	Borrowings On Revolving Funding Facility Ii Net BorrowingsOnRevolvingFundingFacilityIINet		usd
	kbdc	Deposits For Issuance Of Common Shares DepositsForIssuanceOfCommonShares		usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
CY2023Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3		usd
	us-gaap	Investment Company Issuance Of Shares Per Share InvestmentCompanyIssuanceOfSharesPerShare
	us-gaap	Investment Company Repurchase Of Shares Per Share InvestmentCompanyRepurchaseOfSharesPerShare
	us-gaap	Investment Company Repurchase Of Shares Per Share InvestmentCompanyRepurchaseOfSharesPerShare
	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
CY2023Q3	us-gaap	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare
	us-gaap	Investment Company Total Return Market Value InvestmentCompanyTotalReturnMarketValue		pure
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001747172

Files In Submission

Name	View Source	Status
0001213900-24-097564-index-headers.html	Edgar Link	pending
0001213900-24-097564-index.html	Edgar Link	pending
0001213900-24-097564.txt	Edgar Link	pending
0001213900-24-097564-xbrl.zip	Edgar Link	pending
ea0218487-10q_kayne.htm	Edgar Link	pending
ea021848701ex21-1_kayne.htm	Edgar Link	pending
ea021848701ex31-1_kayne.htm	Edgar Link	pending
ea021848701ex31-2_kayne.htm	Edgar Link	pending
ea021848701ex32-1_kayne.htm	Edgar Link	pending
ea021848701ex32-2_kayne.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
kbdc-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
kbdc-20240930_cal.xml	Edgar Link	unprocessable
kbdc-20240930_def.xml	Edgar Link	unprocessable
kbdc-20240930_pre.xml	Edgar Link	unprocessable
kbdc-20240930_lab.xml	Edgar Link	unprocessable
ea0218487-10q_kayne_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$KBDC
Kayne Anderson BDC Inc Stock $kbdc

2024 Q4 Form 10-Q Financial Statement

#000121390024097564 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBDC Kayne Anderson BDC Inc Stock $kbdc

2024 Q4 Form 10-Q Financial Statement

#000121390024097564 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$KBDC
Kayne Anderson BDC Inc Stock $kbdc